Clover Health Investments Corp is trading 4.3% down at $4.73 as the stock pulls back following a significant multi-day rally driven by regulatory optimism.
- The recent surge was sparked by a court-ordered upgrade of the company's 2026 Medicare Star Rating to 4.5 stars, which is expected to result in higher Medicare payments in 2027.
- Today's decline appears to be a bout of profit-taking and price normalization following those strong gains.
- Broader market indices are trading roughly flat to slightly mixed, providing little additional direction for the healthcare sector.